“With today's decision, an updated vaccine will shortly become available that helps address multiple Omicron XBB-related sublineages, which currently account for the vast majority of COVID-19 cases globally,” said Prof. Ugur Sahin, M.D., CEO and Co-founder of BioNTech. ...
Will updated boosters outperform original shots? White House still hopeful Recent small studies, not yet peer-reviewed, suggested the new boosters may not be significantly better than the original vaccine formula. Oct 28, 2022 Pfizer says tweaked COVID shots boost omicron protection ...
Pfizer and BioNTech have said that two doses of their vaccinemay not be sufficient to protect against infectionwith the omicron variant and a booster may be needed to guard against infection and serious illness. Early data suggests the variant is able to evade some of the protection...
For the 5- to 11-year-olds, it's not clear how much demand there will be for boosters. Only about 30% of that age group have had the initial two Pfizer doses since vaccinations opened to them in November. But in a small study, Pfizer found a booster revved up those ...
The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older The KP.2 adaptation is based on FDA guidance, which stated that KP.2 is the preferred strain f
By Kelly Hayes Updated May 17, 2022 10:59am EDT News FOX TV Digital Teamarticle FILE IMAGE - A healthcare worker administers a Pfizer-BioNTech COVID-19 vaccine to a child at a testing and vaccination site in San Francisco, California, on Jan. 10, 2022. Photographer: David Paul ...
In early January, researchers from the University of Texas and Pfizer published a preprint study suggesting that Pfizer’s COVID-19 vaccine could protect against a mutation discovered in the U.K. and South Africa. Two weeks later, though, news emerged th...
Followingthis week's recommendationfrom the Centers for Disease Control and Prevention, certain older Americans and those considered at high risk for complications from COVID-19 who received two doses of the Pfizer-BioNTech vaccine will now qualify for booster shots. While there...
Children ages 12 to 15 are now eligible forPfizerandBioNTech's Covid booster shots, giving them an extra dose of protection as they return to school amid an unprecedented surge of infections across the U.S. The Centers for Disease Control and Prevention on Wednesday recommended the bo...
The studies weren't designed to track how well updated boosters prevented COVID-19 cases. Nor is it clear how long any added protection would last. But the FDA's scientific advisers will publicly debate the data on Tuesday, as they grapple with whether to recommend a change to the vaccines...